P619: TRACKING DISEASE PARAMETERS BY MRD, CT AND PET IN FIRST LINE CLL PATIENTS TREATED WITH FIXED DURATION IBRUTINIB-VENETOCLAX; INTERIM ANALYSIS OF THE FIRST 30 PATIENTS IN HOVON 158/NEXT STEP TRIAL.

Subjects

Subjects :

Diseases of the blood and blood-forming organs
RC633-647.5

Details

Language :

English

ISSN :

25729241

Volume :

7

Database :

Directory of Open Access Journals

Journal :

HemaSphere

Publication Type :

Academic Journal

Accession number :

edsdoj.f1784e57be41248dd5770881eba9b2

Document Type :

article

Full Text :

https://doi.org/10.1097/01.HS9.0000969380.79786.1a